Neurodegeneration
Can we take aggregates apart, instead of slowing their spread?
We’re targeting the protein clumps behind Alzheimer’s, Parkinson’s, ALS and prion disease.
We’re a research company using AI-assisted, novel mathematics to find new angles on medicine’s oldest problems.
It’s slow, it’s expensive, and it breaks down when the target mutates, hides or has no lock at all. The usual answer is more of the same: more compounds, more compute, more trials.
The standard playbook is scale: screen more molecules, train bigger models on past drugs, and hope something fits. We take a different posture. We work at the frontier of mathematics, with AI as an instrument, to describe disease in terms no one has written down before. A new description gives a new angle, and new angles are how old problems finally move.
How many more molecules can we screen?
What question hasn’t anyone thought to compute?
When a problem has resisted decades of effort, we assume the description is the bottleneck, and we go looking for a better one.
We use AI to explore, check and accelerate the work, while our models stay grounded in physics and mathematics rather than in pattern-matching on the past.
The same foundations serve neurology, infection and oncology. Moving into a new disease area means asking a new question, not building a new company.
Can we take aggregates apart, instead of slowing their spread?
We’re targeting the protein clumps behind Alzheimer’s, Parkinson’s, ALS and prion disease.
Can one mechanism work across virus families?
Instead of fighting one strain at a time, we’re looking for a mechanism that isn’t tied to any single viral protein, so a mutation alone can’t get around it.
What can’t a bacterium give up without dying?
We’re aiming at exactly that, to close off the usual route to resistance.
Which patients will respond, before treatment begins?
We’re working to match therapy to the individual tumor, instead of to the average patient.
Where exactly is a structure weakest?
We’re mapping that point precisely, so a drug can act where it does the most good with the least collateral damage.
Every world-class hub started somewhere. Silicon Valley was orchards once. It took a few people who decided not to wait for permission.
Why not us.
Why not here.
Why not now.
We’re building a team of mathematicians, physicists, biologists and engineers who would rather find a new angle than run the old one faster. If an age-old problem has always bothered you, we should talk.
Geometry, topology, dynamical systems. People who invent the tools, not just apply them.
Introduce yourself →Statistical mechanics and biophysics, turning molecular behavior into something computable.
Introduce yourself →Protein structure, aggregation, host–pathogen and tumor biology.
Introduce yourself →AI that helps search, prove and check, not just predict.
Introduce yourself →Medicinal and structural chemists who turn a computed angle into a molecule.
Introduce yourself →Fast, verifiable scientific software built to the standard of a lab notebook.
Introduce yourself →For investors, research labs and collaborators who want to test a different starting point for drug discovery.
[email protected] →